SOAT1 and ovarian serous cystadenocarcinoma: There was no significant difference in SOAT1 expression in seven cancers, bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), ovarian serous cystadenocarcinoma (OV), sarcoma (SARC), THYM, uterine corpus endometrial carcinoma (UCEC), and uterine carcinosarcoma (UCS) (Fig. 1C).